{"url_path":"/sec/fmhs/10-q/2026/item-2","section_key":"item-2","section_title":"Item 2 UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-20","source_url":"https://www.sec.gov/Archives/edgar/data/1811999/0001096906-26-000845-index.html","accession_number":"0001096906-26-000845","cik":"0001811999","ticker":"FMHS","issuer_name":"FARMHOUSE, INC. /NV","edgar_url":"https://www.sec.gov/Archives/edgar/data/1811999/0001096906-26-000845-index.html","primary_entity_key":"0001811999","primary_entity_name":"FARMHOUSE, INC. /NV"},"word_count":177,"has_tables":true,"body_markdown":"**ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS**\n\nDuring the three months ended March 31, 2026, the Company issued a $10,000 Series 2026 mandatorily convertible note to an unaffiliated investor. The note bears interest at 10% per annum, matures in February 2029, and contains conversion features substantially similar to the Company’s Series 2025 mandatorily convertible notes.\n\nIn addition, on January 16, 2026, the Company issued 50,000 shares of restricted common stock for legal services rendered in connection with the Company’s registration statement. The issuance was made in reliance upon the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended, as a transaction not involving a public offering.\n\nThe issuance of the Series 2026 convertible note was completed in reliance upon the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended, and/or Rule 506(b) of Regulation D, as a transaction not involving a public offering. No general solicitation was used, and the investor represented that it was acquiring the security for investment purposes."}